The Aseptic Fill Finish Manufacturing Market is projected to grow at a CAGR of ~10%, till 2035, claims Roots Analysis
29 Aug 2023
The growing concern to maintain pharmacological efficacy and product quality, to ensure patient's safety, has led to a greater focus on the need for aseptic fill / finish; drug developers prefer to outsource these operations to benefit from the expertise of service provid
ers
LONDON, Aug. 29, 2023 /PRNewswire/ --
Roots Analysis has announced the addition of "
Aseptic Fill Finish Market, 2023-2035" report to its list of offerings.
In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products.
To order this 380+ page report, which features 90+ figures and 220+ tables,
please visit
https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html
Key Market Insights
Presently, more than 235 players claim to offer aseptic fill / finish services
Aseptic fill / finish segment of the industry is dominated by the presence of service providers offering fill / finish services related to biopharmaceutical products (47%). This is followed by players offering services related to small molecules (25%), while the remaining companies offer fill / finish services for both type of molecules.
Close to 180 service providers claim to provide services for biologic fill / finish
The biologics fill / finish market landscape is highly fragmented, featuring a mix of small, mid-sized, and large players. It is worth noting that this market is currently dominated by mid-sized players (with 51-500 employees), which represent around 40% of the contemporary market landscape.
Over 125 companies in this domain provide fill / finish services for small molecules
Within this landscape, aseptic filling is the most prevalent type of filling service offered (90%) for the packaging of small molecules. This is followed by terminal sterilization, which is offered by over 40% of the players. It is worth highlighting that around 6% players offer all three types of filling services.
Since 2013, close to 185 partnerships have been established in the aseptic fill / finish services domain
Of these, nearly 36% deals were inked in 2020. Further, majority of the deals were inked to offer fill / finish related services (64%). In addition, more than 60 deals have been inked by players to offer aseptic fill / finish services for vaccines.
By 2035, the market for aseptic fill / finish services is likely to grow at an annualized rate of ~10%
In terms of type of packaging container, the current market is driven by vials (close to 65%); this trend is unlikely to change in the foreseen future as well. Further, based on scale of operation, majority of the revenue share (86%) of the overall market in 2035 is projected to be driven by commercial scale.
North America and Europe are expected to capture more than 65% of the market share by 2035
In terms of type of biologics, antibodies and vaccines are expected to occupy a larger share (~70%) of the total aseptic fill / finish services market in 2035. Further, close to 40% of the aseptic fill / finish services market share for therapeutic areas is captured by oncological disorders.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/aseptic-fill-finish-market/request-sample.html
Key Questions Answered
What is the aseptic fill finish?
What are the requirements and considerations for aseptic fill finish operations?
How many players are providing aseptic fill finish services?
What are the latest trends in aseptic fill finish services market?
What is the growth rate of aseptic fill finish services market?
Which region captures the largest share of the aseptic fill finish services market?
Which segment, in terms of type of molecule, currently accounts for the largest share of the aseptic fill finish services market?
Which type of packaging containers are most widely used in the aseptic fill finish services market?
What type of partnerships are taking place in the aseptic fill finish services market?
The financial opportunity within the aseptic fill finish market has been analyzed across the following segments:
Type of Molecule
Small molecules
Biologics
Type of Packaging Container
Ampoules
Cartridges
Syringes
Vials
Type of Drug Product
Antibodies
Cell Therapies
Gene Therapies
Oligonucleotides
Recombinant Proteins
Vaccines
Other Drug Products
Target Therapeutic Area
Oncological Disorders
Other Disorders
Scale Of Operation
Preclinical / Clinical
Commercial
Company Size
Large
Mid-sized
Small
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
The report features inputs from eminent industry stakeholders, according to whom, a significant increase in the demand for cell and gene therapies is anticipated to drive the growth of the aseptic fill / finish market. The report includes detailed transcripts of discussions held with the following experts:
Gregor Kawaletz (Chief Commercial Officer, IDT Biologika)
Matt Delaney (Vice President Business Development & Marketing, Cytovance Biologics)
Purushottam Singnurkar (Research Director and Head of Formulation Development, Syngene International)
Ales Sima (Business Development Manager, Oncomed Manufacturing)
Amit Chandra (Technology Watch Manager, Yposkesi)
Jos Vergeest (International Business Developer, HALIX)
The research also includes detailed profiles of key players (listed below) engaged in offering biologics fill / finish services; each profile features a brief overview of the company, its financial information (if available), details on aseptic fill / finish services, location of facilities, recent developments and an informed future outlook.
Aenova
BioReliance
Catalent Biologics
CordenPharma
Delpharm
Fareva
Fresenius Kabi
Hetero Drugs
Lonza
Pierre Fabre
PiSA Farmaceutica
Plastikon Healthcare
Recipharm
Sharp Services
Siegfried
Wockhardt
For additional details, please visit
https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html
You may also be interested in the following titles:
1. Conjugation and Labeling Services Market: Industry Trends and Global Forecasts, 2023-2035
2. Genotoxicity Testing and Mutagenicity Testing Services Market: Industry Trends and Global Forecasts, 2023-2035
3. Biologics Fill Finish Services Market (3rd Edition): Industry Trends and Global Forecasts, 2023-2035
4. Biopharmaceutical Contract Manufacturing Market: Industry Trends and Global Forecasts, 2023-2035
5. Cell and Gene Therapy CRO Market (3rd Edition): Industry Trends and Global Forecasts, 2023-2035
6. Lyophilization Services Market: Industry Trends and Global Forecasts, 2022-2035
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]
Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
SOURCE Roots Analysis
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.